4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:原厂直采,平行进口,授权代理(蚂蚁淘为您服务)
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > peptide > Addgene/pAAV-2Aneo/1单元/80032
商品详细Addgene/pAAV-2Aneo/1单元/80032
Addgene/pAAV-2Aneo/1单元/80032
Addgene/pAAV-2Aneo/1单元/80032
商品编号: 80032
品牌: Addgene inc
市场价: ¥1500.00
美元价: 750.00
产地: 美国(厂家直采)
公司:
产品分类: 多肽合成
公司分类: peptide
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍

Ordering

ItemCatalog #DescriptionQuantityPrice (USD)
Plasmid80032Standard format: Plasmid sent in bacteria as agar stab1$75
Add to Cart

This material is available to academics and nonprofits only.

Backbone

  • Vector backbone
    pAAV-MCS
    (Search Vector Database)
  • Backbone manufacturer
    Stratagene
  • Backbone size(bp)2892
  • Modifications to backbone
    a NotI-NotI fragment containing pAAV-MCS backbone was used for the cloning of pAAV-2Aneo.
  • Vector type
    AAV, Cre/Lox ; a platform vector to construct targeting vectors by inserting 5' and 3' arms
  • Selectable markers
    Neomycin (select with G418)

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin
  • Growth Temperature
    37°C
  • Growth Strain(s)
    NEB Stable
  • Copy number
    High Copy

Cloning Information

  • Cloning methodRestriction Enzyme
  • 5′ sequencing primerSK primer
  • 3′ sequencing primerKS primer
  • (Common Sequencing Primers)

Resource Information

  • Terms and Licenses
    • UBMTA
  • Industry Terms
    • Not Available to Industry

Depositor Comments

Upon construction of a targeting vector with pAAV-2Aneo, the “frame adjuster” should be first cleaved with BspEI, MluI, or BsrGI and then self-religated so that 2Aneo is translated in frame with the 5’ portion of the targeted endogenous gene.This truncation of the frame adjuster should be done prior to the incorporation of 5' and 3' arms into pAAV-2Aneo, if arms carry restriction enzyme sites cleaved during the truncation of the frame adjuster (i.e., BspEI, MluI, or BsrGI sites).This plasmid and pAAV-2Aneo v2 differ only by the sequences of the frame adjusters.

A following article describes how to use pAAV-2Aneo to construct AAV-based targeting vectors: Karnan et al. Bio-Protoc, 6(24): e2058, 2016. (http://www.bio-protocol.org/e2058)

品牌介绍
Addgene腺相关病毒(AAV)是最初被发现为腺病毒原种污染物的小型病毒。使用AAV进行研究的一个主要优点是它受复制限制,通常不引起人类疾病。由于这些原因,AAV通常以较低的生物安全水平被包含并且在体内引起相对较低的免疫学作用。虽然AAV可以在BSL-1处理,但表达癌基因或毒素的AAV应该在BSL-2处理。AAV可以以低免疫应答和低毒性转导分裂和非分裂细胞。尽管重组AAV不能整合到宿主基因组中,但转基因表达可以长期存在。目前,AAV的实用性受到其小包装容量(包括ITR在内约4.5 kb)的限制,尽管有很多兴趣和精力来扩大这种容量。传统上,AAV需要存在另一种“辅助”病毒(例如腺病毒或疱疹病毒)才能传播。这是由于AAV对某些介导AAV复制的外源基因产物的依赖。“无辅助病毒的系统”已经绕过了这一要求,该系统无需使用辅助病毒就可以生产感染性AAV颗粒。替代地,可以在AAV生产过程中通过辅助质粒(例如pHelper)和特异性包装细胞系(例如HEK293细胞)提供特异性基因产物。